According to reports, an estimated 7.74 million people lived with sickle cell disease in 2021. Sickle cell anaemia can be a ...

Paris: Sanofi has received orphan drug designation from the US Food and Drug Administration (FDA) for rilzabrutinib, a novel, ...

The Pediatric Emergency Medicine and Pediatric Hematology/Oncology divisions at MUSC have joined forces to create and test an ...

Rilzabrutinib granted orphan drug designation in the US for sickle cell disease <li /> Fourth orphan drug designation for rilzabrutinib ...

The Pediatric Emergency Medicine and Pediatric Hematology/Oncology divisions at the Medical University of South Carolina ...

For the first time in his life, a young New Jersey man is pain-free thanks to a new gene treatment working to cure patients ...

Individuals with both sickle cell disease (SCD) and sickle cell trait are at higher risk than others of developing renal medullary cancer (RMC), the rarest and deadliest subtype of kidney cancer.

It is one hour at a time for Gladicy Mbeyu, a sickle cell warrior who was last year awarded a state commendation for helping ...

Sanofi SNY announced that the FDA has granted orphan drug designation to its investigational BTK inhibitor, rilzabrutinib, ...

THAT’S WHAT WE’RE LOOKING FOR. SO THERE ARE MORE THAN 100,000 PEOPLE ESTIMATED TO HAVE SICKLE CELL DISEASE IN THE U.S., THE RED CROSS SAYS FOSTERING A DIVERSE BLOOD SUPPLY IS CRITICALLY ...

Living with sickle cell disease presents many physical and emotional challenges. From painful crises to the risk of organ damage, individuals with SCD often carry a heavy health burden. Among the many ...